Headlines
- An Interview With Elemer Piros: A Strong Year For Biotechs, Looking From The Halfway Pointat Seeking Alpha(Tue 11:34AM EDT)
- Where Is Biotechnology's Next 'Anti-PD-1'?at Seeking Alpha(Tue 7:57AM EDT)
- J&J to Buy Aragon Pharmaceuticals for Cancer Candidateat Bloomberg(Mon Jun 17)
- Beware the Bullishness on Bristol-Myersat Motley Fool(Sun Jun 16)
- One Person's Trash Is Another Person's Treasure Portfolioat Motley Fool(Thu Jun 13)
- Analysts: MasterCard Volume Is Growing Faster Than Thought and 3 More Research Notes to Readat Wall St. Cheat Sheet(Thu Jun 13)
- 3 Reasons You Shouldn't Buy Stocks in Biotechat Motley Fool(Thu Jun 13)
- 5 Names With Sharp Rises In Short Interestat Seeking Alpha(Thu Jun 13)
- Largest option buying in equities so faroptionMONSTER(Wed Jun 12)
- When It Comes To Biotech, Diversity Is Keyat Seeking Alpha(Wed Jun 12)
- A Promising Platform for Cancer Immunotherapyat Motley Fool(Sat Jun 8)
- SmithOnStocks Opines Week Of June 2, 2013at Seeking Alpha(Mon Jun 3)
- 4 Healthcare Stock Stories To Close Out the Weekat Wall St. Cheat Sheet(Fri May 31)
- This Cancer Drug Developer Could Really Use a Partnerat Motley Fool(Fri May 31)
- Toyota’s Cautious Approach to China, Dell Urges Shareholders In Favor of Dell-Silverlake, and 3 More Hot Stocksat Wall St. Cheat Sheet(Fri May 31)
Press Releases
- StockCall Pre-Market Review on DNDN, SRPT, ACAD, CTIC, and MDVNAccesswire(Wed May 8)
- How Cancer Beats the Immune SystemAccesswire(Thu Mar 7)
Must Read
- Dish abandons Sprint bid for now to focus on ClearwireReuters(1969-12-31T18:59:59GMT-05:00)
- Verizon CFO says U.S. wireless carrier looking at potential entry into CanadaThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Hudson's Bay Company names Bonnie Brooks to vice-chairmanThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- RBC analyst says BlackBerry should be profitable this fiscal yearThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- G8 pledges action on tax evasion, few concrete measuresReuters(1969-12-31T18:59:59GMT-05:00)
